Philippe Antoine Bilodeau, Anastasia Vishnevetsky, Negar Molazadeh, Itay Lotan, Monique Anderson, Gabriela Romanow, Rebecca Salky, Brian C Healy, Marcelo Matiello, Tanuja Chitnis, Michael Levy
BACKGROUND: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can cause optic neuritis, transverse myelitis, or acute disseminated encephalomyelitis (ADEM). Immunotherapy is often used for relapsing disease, but there is variability in treatment decisions. OBJECTIVE: The objective was to determine the annualized relapse rates (ARRs) and incidence rate ratios (IRRs) compared to pre-treatment and relapse-freedom probabilities among patients receiving steroids, B-cell depletion (BCD), intravenous immunoglobulin (IVIG), and mycophenolate mofetil (MMF)...
March 2024: Multiple Sclerosis: Clinical and Laboratory Research